Prelude Therapeutics to Participate in Three Healthcare Investor Conferences in September
August 29, 2023 08:30 ET
|
Prelude Therapeutics, Inc.
WILMINGTON, Del., Aug. 29, 2023 (GLOBE NEWSWIRE) -- Prelude Therapeutics Incorporated (Nasdaq: PRLD), a clinical-stage precision oncology company, today announced that company executives will...
Correction: Nuvectis Pharma, Inc. to Present at the H.C. Wainwright BioConnect Investor Conference
April 27, 2023 10:14 ET
|
Nuvectis Pharma, Inc.
FORT LEE, NJ, April 27, 2023 (GLOBE NEWSWIRE) -- In the news release, Nuvectis Pharma, Inc. to Present at the H.C. Wainwright BioConnect Investor Conference, please note that the conference date is...
Nuvectis Pharma, Inc. to Present at the H.C. Wainwright BioConnect Investor Conference
April 27, 2023 08:00 ET
|
Nuvectis Pharma, Inc.
FORT LEE, NJ, April 27, 2023 (GLOBE NEWSWIRE) -- Nuvectis Pharma, Inc. (“Nuvectis”, “Company”), a biopharmaceutical company focused on the development of innovative precision medicines for the...
GT Biopharma to Participate in the H.C. Wainwright Cell Therapy Virtual Conference
February 24, 2023 09:00 ET
|
GT Biopharma, Inc.
BRISBANE, CALIFORNIA, Feb. 24, 2023 (GLOBE NEWSWIRE) -- GT Biopharma, Inc. (NASDAQ: GTBP), a clinical stage immuno-oncology company focused on developing innovative therapeutics based on the...
Freight Technologies, Inc., to Participate in H.C. Wainwright 24th Annual Global Investment Conference
September 14, 2022 07:05 ET
|
Freight Technologies Inc
HOUSTON, Sept. 14, 2022 (GLOBE NEWSWIRE) -- via InvestorWire -- Freight Technologies, Inc. (Nasdaq: FRGT, Fr8Tech), a technology company developing solutions to optimize and automate the supply...
Celsion Corporation Presentation Time at the H.C. Wainwright 24th Annual Global Investment Conference Changed to 4:30 p.m. ET on September 13
September 12, 2022 18:30 ET
|
Celsion Corporation
LAWRENCEVILLE, N.J., Sept. 12, 2022 (GLOBE NEWSWIRE) -- Celsion Corporation (NASDAQ: CLSN), a clinical-stage drug development company, announces that Dr. Corinne Le Goff, President and Chief...
MetaWorks Announces Participation at the H.C. Wainwright 24th Annual Global Investment Conference
September 09, 2022 16:30 ET
|
MetaWorks Platforms, Inc
Fairfield, CA., Sept. 09, 2022 (GLOBE NEWSWIRE) -- MetaWorks Platforms, Inc. (“MetaWorks” or the “Company”), (CSE: MWRK and OTCQB: MWRK), an award-winning, full-service Web3 blockchain platform...
CareCloud to Present at the H.C. Wainwright 24th Annual Global Investment Conference on Monday, September 12
September 09, 2022 08:30 ET
|
CareCloud, Inc
SOMERSET, N.J., Sept. 09, 2022 (GLOBE NEWSWIRE) -- CareCloud, Inc. (the “Company”) (Nasdaq: MTBC, MTBCO, MTBCP), a leader in healthcare technology solutions for medical practices and health systems...
Locafy to Present at the H.C. Wainwright 24th Annual Global Investment Conference
September 09, 2022 08:00 ET
|
Locafy Limited
PERTH, Australia, Sept. 09, 2022 (GLOBE NEWSWIRE) -- Locafy Limited (Nasdaq: LCFY, LCFYW) (“Locafy” or “the Company”), a globally recognized software-as-a-service technology company specializing in...
InflaRx to Present at Upcoming Scientific and Investor Conferences
September 09, 2022 07:30 ET
|
InflaRx N.V.
JENA, Germany, Sept. 09, 2022 (GLOBE NEWSWIRE) -- InflaRx N.V. (Nasdaq: IFRX), a clinical-stage biopharmaceutical company developing anti-inflammatory therapeutics by targeting the complement...